BAGANBAZAR GRAPHEXPLORE · ANALYZE · GROW
Theme
LiveDesk
WorldNovo Nordisk CEO defends economics of Wegovy pill as lower prices weigh on sales; shares fall 5%TechnologyMajor bank joins fight against draft crypto rulesTechnology‘Really embarrassing’: SA expert on OpenAI’s agent escapeTechnologyThe steam engine lesson AI doomsayers keep missingTechnologyGEC+Africa 2026 celebrates Africa’s most promising entrepreneurs
World/Source-attributed reporting
World DESK

Novo Nordisk CEO defends economics of Wegovy pill as lower prices weigh on sales; shares fall 5%

Wall Street isn't convinced the Ozempic maker has a promising path back to sustainable growth as competition from Eli Lilly intensifies.

Published Aug 17, 2026 · 1:12 AMOriginal source: Consumer News and Business Channel17 reads
Wall Street isn't convinced the Ozempic maker has a promising path back to sustainable growth as competition from Eli Lilly intensifies.
ORIGINAL SOURCE

Consumer News and Business Channel

This report is indexed by BAGANBAZAR GRAPH with its original publisher named and linked for readers.

Read at original outlet ↗
RELATED COVERAGE

More from this desk.

Ukrainian arms producers warn competitive edge eroding due to stringent export licence rulesSource linked
World

Ukrainian arms producers warn competitive edge eroding due to stringent export licence rules

Russian drones struck Ukraine's National Academy of Sciences in the historic heart of Kyiv on Monday, in the latest deadly daytime attack on the capital. Volodymyr Zelensky has long been pleading with Ukraine’s allies for more military aid to fend off Russia. But Ukrainian weapons producers say the country could be bringing in significant revenue of its own, if only they were allowed to export their products. FRANCE 24's Gulliver Cragg reports from Kyiv.

SourceFrance 24